CN108034693A - The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers - Google Patents

The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers Download PDF

Info

Publication number
CN108034693A
CN108034693A CN201810077354.4A CN201810077354A CN108034693A CN 108034693 A CN108034693 A CN 108034693A CN 201810077354 A CN201810077354 A CN 201810077354A CN 108034693 A CN108034693 A CN 108034693A
Authority
CN
China
Prior art keywords
culture
bacteria suspension
cultures
small
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810077354.4A
Other languages
Chinese (zh)
Inventor
张静
翟卫东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Laneva Pharmaceutical Co Ltd
Original Assignee
Beijing Laneva Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Laneva Pharmaceutical Co Ltd filed Critical Beijing Laneva Pharmaceutical Co Ltd
Priority to CN201810077354.4A priority Critical patent/CN108034693A/en
Publication of CN108034693A publication Critical patent/CN108034693A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06Quantitative determination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/10Enterobacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14Streptococcus; Staphylococcus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention belongs to drug measurement techniques field, and in particular to a kind of microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers.The microbial limit tests of the Bisoprolol Hemifumarate Capsule in Healthy Volunteers, step are as follows:(1) prepared by bacterium solution;(2) prepared by test liquid:Bisoprolol Hemifumarate Capsule in Healthy Volunteers test sample 10g is taken, is placed in sterile homogenizing bag, adds 45 DEG C of pH7.0 sterile NaCl peptone buffer agents of 100mL, 1min is patted with homogenizer, shakes up, as 1:10 test liquid;(3) aerobic bacteria, the measure of yeast and mold sum;(4) inspection of escherichia coli.The present invention can prevent the appearance of sample false negative in checkout procedure, reduce patient medication security risk.

Description

The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers
Technical field
The invention belongs to drug measurement techniques field, and in particular to a kind of microbial limit of Bisoprolol Hemifumarate Capsule in Healthy Volunteers Inspection method.
Background technology
Bisoprolol fumarate, is beta-blocker, has high-affinity to the β1-receptor of bronchus and vascular smooth muscle, So as to distend the blood vessels, blood pressure reduces.Suitable for hypertension, coronary heart disease and moderate to severe chronic stable heart failure etc. Disease.Bisoprolol Hemifumarate Capsule in Healthy Volunteers is suitable for the treatment of essential hypertension, is more commonly used in bisoprolol fumarate's medicine One kind.
The limitation standard in microbe of non-sterile medicine is method of administration based on medicine and potentially hazardous to patient health And Chinese medicine particularity and work out.Microbial decolorization system check it is non-regulation sterilization preparation and its raw material, auxiliary material by The method of microbial contamination degree.Inspection item includes bacterial population, fungi count, yeast count and Control bacteria examination.
Microbial limit tests on Bisoprolol Hemifumarate Capsule in Healthy Volunteers not yet have been reported that so far.
The content of the invention
The object of the present invention is to provide a kind of microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers, in microorganism The phenomenon of false negative is avoided during limit test, reduces patient medication security risk.
The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers of the present invention, step are as follows:
(1) prepared by bacterium solution
Staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, white is prepared respectively Color candida albicans bacteria suspension and aspergillus niger spore suspension;
(2) prepared by test liquid
Bisoprolol Hemifumarate Capsule in Healthy Volunteers test sample 10g is taken, is placed in sterile homogenizing bag, adds 45 DEG C of pH7.0 of 100mL sterile Sodium chloride-peptone buffer agent, pats 1min with homogenizer, shakes up, as 1:10 test liquid;
(3) aerobic bacteria, the measure of yeast and mold sum
1. test sample group
Take 1:10 test liquid 1mL note wares, pour into pancreas junket soy agar culture medium, and plate is inverted 30~35 DEG C and is cultivated 5 days;
Take 1:10 test liquid 1mL note wares, pour into Sabouraud glucose agar, and plate is inverted 20~25 DEG C of cultures 7 My god;
2. bacterium solution group
Take pH7.0 sterile NaCls-peptone buffer agent 9.9mL and 0.1mL bacterium solution to mix, take 1mL to note ware;
Wherein, staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, white Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in pancreas junket soya peptone agar medium, and plate is inverted 30~35 DEG C Culture 3 days;
Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in Sabouraud glucose agar, plate 20~25 DEG C are inverted to cultivate 5 days;
3. test group
Take 1:10 test liquid 9.9mL and 0.1mL test organisms mixes, and takes 1mL to note ware,
Wherein, staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, white Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in pancreas junket soya peptone agar medium, and plate is inverted 30~35 DEG C Culture 3 days;Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in Sabouraud glucose agar, plate 20~25 DEG C are inverted to cultivate 5 days;
4. aerobic bacteria, the measure of yeast and mold sum are carried out after each plate culture
Test group clump count subtracts the value of test sample group clump count and the ratio of bacterium solution group clump count in the range of 0.5~2 It is as qualified;
(4) inspection of escherichia coli
1. prepared by bacterium solution:
Prepare escherichia coli bacteria suspension;
2. inspection method:
Test sample group:Take 1:10 test liquid 10mL, adds in 100mLTSB culture mediums, mixes, 30~35 DEG C of cultures 18 ~72 it is small when, obtain culture;Above-mentioned culture 1mL is taken to be seeded in 100mL Mai Kangkai fluid nutrient mediums, 42~44 DEG C of cultures 24~48 it is small when;Taking the streak inoculation of Mai Kangkai liquid cultures, 30~35 DEG C are cultivated 18 on maconkey agar culture medium flat plate ~72 it is small when;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, though or there is colony growth identification to tie Fruit is feminine gender, judges that test sample group does not detect escherichia coli;
Test group:Take 1:10 test liquid 10mL and no more than 100cfu escherichia coli add 100mLTSB culture mediums In, mix, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to be seeded to 100mL Mai Kangkai liquid In body culture medium, when 42~44 DEG C of cultures 24~48 are small;The streak inoculation of Mai Kangkai liquid cultures is taken in maconkey agar culture On base tablet, when 30~35 DEG C of cultures 18~72 are small;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, Or though it is feminine gender to have colony growth but qualification result, judges that test group does not detect escherichia coli;
Positive controls:Take pH7.0 sterile NaCls-peptone buffer agent 10mL and no more than 100cfu escherichia coli Add in 100mLTSB culture mediums, mix, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to connect Kind is into 100mL Mai Kangkai fluid nutrient mediums, when 42~44 DEG C of cultures 24~48 are small;Take Mai Kangkai liquid culture streak inoculations In on maconkey agar culture medium flat plate, when 30~35 DEG C of cultures 18~72 are small;If as a result judging, maconkey agar culture medium is put down There is no colony growth on plate, though or have colony growth qualification result for feminine gender, it is uncommon to judge that positive controls do not detect large intestine angstrom Bacterium;
Negative control group:Take pH7.0 sterile NaCls-peptone buffer agent 10mL to add in 100mLTSB culture mediums, mix It is even, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to be seeded to 100mL Mai Kangkai Liquid Cultures In base, when 42~44 DEG C of cultures 24~48 are small;The streak inoculation of Mai Kangkai liquid cultures is taken in maconkey agar culture medium flat plate On, when 30~35 DEG C of cultures 18~72 are small;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, though or have Colony growth but qualification result are feminine gender, judge that negative control group does not detect escherichia coli.
In step (1) preparation method of staphylococcus aureus bacteria suspension learn from else's experience 30~35 DEG C culture 18~24 it is small when Staphylococcus aureus fresh cultured thing, it is 5000~10000cfu that every 1mL, which is made, containing bacterium number with 0.9% aseptic sodium chloride solution Bacteria suspension.
In step (1) preparation method of pseudomonas aeruginosa bacteria suspension be learn from else's experience 30~35 DEG C culture 18~24 it is small when copper Green pseudomonad fresh cultured thing, every 1mL is made containing the bacterium that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution Suspension.
In step (1) preparation method of bacillus subtilis bacteria suspension be learn from else's experience 30~35 DEG C culture 18~24 it is small when it is withered Careless bacillus fresh cultured thing, every 1mL is made containing the bacterium that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution Suspension.
The preparation method of Candida albicans bacteria suspension is 20~25 DEG C of Candida albicans for cultivating 2~3 days of learning from else's experience in step (1) Bacterium fresh cultured thing, every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution.
In step (1) preparation method of aspergillus niger spore suspension be learn from else's experience 20~25 DEG C culture 5~7 days aspergillus niger it is new Fresh culture, adds 3~5mL, 0.9% aseptic sodium chloride solutions, spore is eluted, and suctions out in spore suspension to sterile test tube, uses Every 1mL is made containing the spore suspension that spore count is 5000~10000cfu in 0.9% aseptic sodium chloride solution.
In step (4) preparation method of escherichia coli bacteria suspension be learn from else's experience 30~35 DEG C culture 18~24 it is small when large intestine Angstrom uncommon bacterium fresh cultured thing, is made every 1mL with 0.9% aseptic sodium chloride solution and is hanged containing the bacterium that bacterium number is 5000~10000cfu Liquid.
Compared with prior art, the present invention have the advantages that:
The present invention can prevent the appearance of sample false negative in checkout procedure, reduce patient medication security risk.
Embodiment
The present invention is described further with reference to embodiments.
Embodiment 1
(1) prepared by bacterium solution
1. staphylococcus aureus, pseudomonas aeruginosa, bacillus subtilis
Pseudomonas aeruginosa, staphylococcus aureus, bacillus subtilis when 30~35 DEG C of cultures 18~24 of learning from else's experience are small Fresh cultured thing, every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution.
2. Candida albicans
Learn from else's experience 20~25 DEG C of cultures Candida albicans fresh cultured things of 2~3 days, with 0.9% aseptic sodium chloride solution system Into every 1mL containing the bacteria suspension that bacterium number is 5000~10000cfu.
3. aspergillus niger
Learn from else's experience 20~25 DEG C culture 5~7 days aspergillus niger fresh cultured thing, add 3~5mL, 0.9% sterile NaCls molten Liquid, spore is eluted, and suctions out in spore suspension to sterile test tube, every 1mL is made with 0.9% aseptic sodium chloride solution and contains spore count For the spore suspension of 5000~10000cfu.
(2) prepared by test liquid
Bisoprolol Hemifumarate Capsule in Healthy Volunteers test sample 10g is taken, is placed in sterile homogenizing bag, adds 45 DEG C of pH7.0 of 100mL sterile Sodium chloride-peptone buffer agent, pats 1min with homogenizer, shakes up, as 1:10 test liquid.
(3) aerobic bacteria, the measure of yeast and mold sum
1. test sample group
Take 1:10 test liquid 1mL note wares, pour into pancreas junket soy agar culture medium, and plate is inverted 30~35 DEG C and is cultivated 5 days;
Take 1:10 test liquid 1mL note wares, pour into Sabouraud glucose agar, and plate is inverted 20~25 DEG C of cultures 7 My god;
Count results are shown in Table 1.
2. bacterium solution group
Take pH7.0 sterile NaCls-peptone buffer agent 9.9mL and 0.1mL bacterium solution to mix, take 1mL to note ware;
Wherein, staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, white Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in pancreas junket soya peptone agar medium, and plate is inverted 30~35 DEG C Culture 3 days;Count results are shown in Table 2;
Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in Sabouraud glucose agar, plate 20~25 DEG C are inverted to cultivate 5 days;Count results are shown in Table 3.
3. test group
Take 1:10 test liquid 9.9mL and 0.1mL test organisms mixes, and takes 1mL to note ware,
Wherein, staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, white Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in pancreas junket soya peptone agar medium, and plate is inverted 30~35 DEG C Culture 3 days, count results are shown in Table 4;Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately to Sabouraud dextrose fine jade In fat culture medium, plate is inverted 20~25 DEG C and is cultivated 5 days, and count results are shown in Table 5.
4. aerobic bacteria, the measure of yeast and mold sum are carried out after each plate culture
Test group clump count subtracts the value of test sample group clump count and the ratio of bacterium solution group clump count in the range of 0.5~2 It is as qualified;Measurement result is shown in Table 6, table 7.Aerobic bacteria, the ratio of yeast and mold are in the range of 0.5~2, and detection is for examination Product are qualified.
1 test sample group count results (unit of table:cfu)
Aerobic bacteria Yeast and mold
0 0
2 aerobic bacteria bacterium solution group count results (unit of table:cfu)
Staphylococcus aureus Pseudomonas aeruginosa Bacillus subtilis Candida albicans Aspergillus niger
78 73 80 65 65
3 yeast and mold bacterium solution group bacterium solution group count results (unit of table:cfu)
Candida albicans Aspergillus niger
85 62
4 aerobic bacteria test group count results (unit of table:cfu)
Staphylococcus aureus Pseudomonas aeruginosa Bacillus subtilis Candida albicans Aspergillus niger
67 70 80 57 62
5 yeast and mold test group count results (unit of table:cfu)
Candida albicans Aspergillus niger
83 57
6 aerobic bacteria ratio of table
Staphylococcus aureus Pseudomonas aeruginosa Bacillus subtilis Candida albicans Aspergillus niger
0.86 0.96 1.00 0.88 0.95
7 yeast and mold ratio of table
Candida albicans Aspergillus niger
0.98 0.92
(4) Control bacteria examination method applicability is tested:The inspection of escherichia coli
1. prepared by bacterium solution:
Escherichia coli fresh cultured thing when 30~35 DEG C of cultures 18~24 of learning from else's experience are small, it is molten with 0.9% sterile NaCl Every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu in liquid.
2. inspection method:
Test sample group:Take 1:10 test liquid 10mL, adds in 100mLTSB culture mediums, mixes, 30~35 DEG C of cultures 18 ~72 it is small when, obtain culture;Above-mentioned culture 1mL is taken to be seeded in 100mL Mai Kangkai fluid nutrient mediums, 42~44 DEG C of cultures 24~48 it is small when;Taking the streak inoculation of Mai Kangkai liquid cultures, 30~35 DEG C are cultivated 18 on maconkey agar culture medium flat plate ~72 it is small when;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, though or there is colony growth identification to tie Fruit is feminine gender, judges that test sample group does not detect escherichia coli;
Test group:Take 1:10 test liquid 10mL and no more than 100cfu escherichia coli add 100mLTSB culture mediums In, mix, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to be seeded to 100mL Mai Kangkai liquid In body culture medium, when 42~44 DEG C of cultures 24~48 are small;The streak inoculation of Mai Kangkai liquid cultures is taken in maconkey agar culture On base tablet, when 30~35 DEG C of cultures 18~72 are small;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, Or though it is feminine gender to have colony growth but qualification result, judges that test group does not detect escherichia coli;
Positive controls:Take pH7.0 sterile NaCls-peptone buffer agent 10mL and no more than 100cfu escherichia coli Add in 100mLTSB culture mediums, mix, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to connect Kind is into 100mL Mai Kangkai fluid nutrient mediums, when 42~44 DEG C of cultures 24~48 are small;Take Mai Kangkai liquid culture streak inoculations In on maconkey agar culture medium flat plate, when 30~35 DEG C of cultures 18~72 are small;If as a result judging, maconkey agar culture medium is put down There is no colony growth on plate, though or have colony growth qualification result for feminine gender, it is uncommon to judge that positive controls do not detect large intestine angstrom Bacterium;
Negative control group:Take pH7.0 sterile NaCls-peptone buffer agent 10mL to add in 100mLTSB culture mediums, mix It is even, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to be seeded to 100mL Mai Kangkai Liquid Cultures In base, when 42~44 DEG C of cultures 24~48 are small;The streak inoculation of Mai Kangkai liquid cultures is taken in maconkey agar culture medium flat plate On, when 30~35 DEG C of cultures 18~72 are small;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, though or have Colony growth but qualification result are feminine gender, judge that negative control group does not detect escherichia coli.
Measurement result is shown in Table 8.
8 escherichia coli employment and suitability test (E & ST) result of table
Test sample Test group Positive bacteria control group Negative control group
- + + -

Claims (7)

1. a kind of microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers, it is characterised in that step is as follows:
(1) prepared by bacterium solution
Staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, white is prepared respectively to read Pearl bacterium bacteria suspension and aspergillus niger spore suspension;
(2) prepared by test liquid
Bisoprolol Hemifumarate Capsule in Healthy Volunteers test sample 10g is taken, is placed in sterile homogenizing bag, adds 45 DEG C of sterile chlorinations of pH7.0 of 100mL Sodium-peptone buffer agent, pats 1min with homogenizer, shakes up, as 1:10 test liquid;
(3) aerobic bacteria, the measure of yeast and mold sum
1. test sample group
Take 1:10 test liquid 1mL note wares, pour into pancreas junket soy agar culture medium, and plate is inverted 30~35 DEG C and is cultivated 5 days;
Take 1:10 test liquid 1mL note wares, pour into Sabouraud glucose agar, and plate is inverted 20~25 DEG C and is cultivated 7 days;
2. bacterium solution group
Take pH7.0 sterile NaCls-peptone buffer agent 9.9mL and 0.1mL bacterium solution to mix, take 1mL to note ware;
Wherein, staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, Candida albicans Bacterium bacteria suspension and aspergillus niger spore suspension are added separately in pancreas junket soya peptone agar medium, and plate is inverted 30~35 DEG C of cultures 3 days;
Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in Sabouraud glucose agar, and plate is inverted 20~25 DEG C are cultivated 5 days;
3. test group
Take 1:10 test liquid 9.9mL and 0.1mL test organisms mixes, and takes 1mL to note ware,
Wherein, staphylococcus aureus bacteria suspension, pseudomonas aeruginosa bacteria suspension, bacillus subtilis bacteria suspension, Candida albicans Bacterium bacteria suspension and aspergillus niger spore suspension are added separately in pancreas junket soya peptone agar medium, and plate is inverted 30~35 DEG C of cultures 3 days;Candida albicans bacteria suspension and aspergillus niger spore suspension are added separately in Sabouraud glucose agar, and plate is inverted 20~25 DEG C are cultivated 5 days;
4. aerobic bacteria, the measure of yeast and mold sum are carried out after each plate culture
Test group clump count subtracts the value of test sample group clump count It is qualified;
(4) inspection of escherichia coli
1. prepared by bacterium solution:
Prepare escherichia coli bacteria suspension;
2. inspection method:
Test sample group:Take 1:10 test liquid 10mL, adds in 100mLTSB culture mediums, mixes, 30~35 DEG C of cultures 18~72 Hour, obtain culture;Above-mentioned culture 1mL is taken to be seeded in 100mL Mai Kangkai fluid nutrient mediums, 42~44 DEG C of cultures 24~ 48 it is small when;Taking the streak inoculation of Mai Kangkai liquid cultures, 30~35 DEG C are cultivated 18~72 on maconkey agar culture medium flat plate Hour;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, though or there is the colony growth qualification result to be Feminine gender, judges that test sample group does not detect escherichia coli;
Test group:Take 1:10 test liquid 10mL and no more than 100cfu escherichia coli add 100mLTSB culture mediums in, mix It is even, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to be seeded to 100mL Mai Kangkai Liquid Cultures In base, when 42~44 DEG C of cultures 24~48 are small;The streak inoculation of Mai Kangkai liquid cultures is taken in maconkey agar culture medium flat plate On, when 30~35 DEG C of cultures 18~72 are small;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, though or have Colony growth but qualification result are feminine gender, judge that test group does not detect escherichia coli;
Positive controls:Take pH7.0 sterile NaCls-peptone buffer agent 10mL and added no more than 100cfu escherichia coli In 100mLTSB culture mediums, mix, when 30~35 DEG C of cultures 18~72 are small, obtain culture;Above-mentioned culture 1mL is taken to be seeded to In 100mL Mai Kangkai fluid nutrient mediums, when 42~44 DEG C of cultures 24~48 are small;Mai Kangkai liquid culture streak inoculations are taken in wheat On Kang Kai agar medium tablets, when 30~35 DEG C of cultures 18~72 are small;If as a result judge on maconkey agar culture medium flat plate There is no colony growth, though or have colony growth qualification result for feminine gender, judge positive controls do not detect escherichia coli;
Negative control group:Take pH7.0 sterile NaCls-peptone buffer agent 10mL to add in 100mLTSB culture mediums, mix, 30 When~35 DEG C of cultures 18~72 are small, culture is obtained;Above-mentioned culture 1mL is taken to be seeded in 100mL Mai Kangkai fluid nutrient mediums, When 42~44 DEG C of cultures 24~48 are small;The streak inoculation of Mai Kangkai liquid cultures is taken on maconkey agar culture medium flat plate, 30 When~35 DEG C of cultures 18~72 are small;If as a result judging there is no colony growth on maconkey agar culture medium flat plate, though or there is a bacterium colony Growth but qualification result are feminine gender, judge that negative control group does not detect escherichia coli.
2. the microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers according to claim 1, it is characterised in that step Suddenly in (1) preparation method of staphylococcus aureus bacteria suspension be learn from else's experience 30~35 DEG C culture 18~24 it is small when golden yellow grape Coccus fresh cultured thing, every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution.
3. the microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers according to claim 1, it is characterised in that step Suddenly in (1) preparation method of pseudomonas aeruginosa bacteria suspension be learn from else's experience 30~35 DEG C culture 18~24 it is small when pseudomonas aeruginosa Fresh cultured thing, every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution.
4. the microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers according to claim 1, it is characterised in that step Suddenly in (1) preparation method of bacillus subtilis bacteria suspension be learn from else's experience 30~35 DEG C culture 18~24 it is small when bacillus subtilis Fresh cultured thing, every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution.
5. the microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers according to claim 1, it is characterised in that step Suddenly the preparation method of Candida albicans bacteria suspension is 20~25 DEG C of Candida albicans fresh cultureds for cultivating 2~3 days of learning from else's experience in (1) Thing, every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution.
6. the microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers according to claim 1, it is characterised in that step Suddenly in (1) preparation method of aspergillus niger spore suspension be learn from else's experience 20~25 DEG C culture 5~7 days aspergillus niger fresh cultured thing, Add 3~5mL, 0.9% aseptic sodium chloride solutions, spore is eluted, suction out in spore suspension to sterile test tube, it is sterile with 0.9% Every 1mL is made containing the spore suspension that spore count is 5000~10000cfu in sodium chloride solution.
7. the microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers according to claim 1, it is characterised in that step Suddenly in (4) preparation method of escherichia coli bacteria suspension be learn from else's experience 30~35 DEG C culture 18~24 it is small when escherichia coli it is fresh Culture, every 1mL is made containing the bacteria suspension that bacterium number is 5000~10000cfu with 0.9% aseptic sodium chloride solution.
CN201810077354.4A 2018-01-26 2018-01-26 The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers Pending CN108034693A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810077354.4A CN108034693A (en) 2018-01-26 2018-01-26 The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810077354.4A CN108034693A (en) 2018-01-26 2018-01-26 The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers

Publications (1)

Publication Number Publication Date
CN108034693A true CN108034693A (en) 2018-05-15

Family

ID=62097444

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810077354.4A Pending CN108034693A (en) 2018-01-26 2018-01-26 The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers

Country Status (1)

Country Link
CN (1) CN108034693A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112980918A (en) * 2019-12-17 2021-06-18 杭州远大生物制药有限公司 Culture medium for detecting mixed bacteria in live bacteria preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112980918A (en) * 2019-12-17 2021-06-18 杭州远大生物制药有限公司 Culture medium for detecting mixed bacteria in live bacteria preparation
CN112980918B (en) * 2019-12-17 2022-12-30 杭州远大生物制药有限公司 Culture medium for detecting mixed bacteria in live bacteria preparation

Similar Documents

Publication Publication Date Title
Hodges Pharmaceutical applications of microbiological techniques
CN108300756A (en) The microbial limit tests of Nifuratel capsule
CN108025022A (en) Hypochloric acid water solution
CN107164454A (en) Benza microbial limit tests
KR20170007312A (en) Microbiological growth media and methods of using the same
CN106868094A (en) The method for quick of antibiotic residue in a kind of raw milk
CN110205355A (en) A kind of highly sensitive detection culture medium of microorganism and its preparation method and application
CN108315384A (en) The microbial limit tests of Nifuratel nystatin expandable vaginal soft capsule
CN108034693A (en) The microbial limit tests of Bisoprolol Hemifumarate Capsule in Healthy Volunteers
CN110151752A (en) A kind of tea polyphenols composition and its preparing the application in anti-streptococcus suis drug
Galkin et al. Development of the method for microbiological purity testing of recombinant human interleukin-7-based product
CN108300755A (en) The microbial limit tests of dispersible tablet of pidotimod
CN106868093A (en) Microbial limit tests in borneol
Adetunji et al. Formation of biofilm by strains of Listeria monocytogenes isolated from soft cheese'wara'and its processing environment
CN105168139B (en) Application of the silver-colored bag palladium nanometer formulation in anti-Cryptococcus infections medicine is prepared
CN108486211A (en) Helicobacter pylori susceptibility detects culture medium and kit
Agbo et al. Prevalence of contaminating microorganisms in anti-malarial drugs sold in Calabar, Cross River State, Nigeria
CN106906274A (en) The ancestor that spreads out educates microbial limit tests in sub- capsule
Elmanama et al. Evaluation of Biofilm Formation of Pseudomonas aeruginosa Isolated from Al-Shifa Hospital and their Susceptibility to Acetic Acid.
CN106148179A (en) Staphylococcus drug sensitive batten and preparation method thereof
RU2103353C1 (en) Strain of bacterium lactobacillus acidophilus used for correction of disbacteriosis at gastroenteric diseases and in patient with large intestine cancer
CN108578400A (en) Application of the nevadensin in preparing anti-candida albicans drug
Okpo et al. Bacteriological quality of chloroquine syrups sold in Calabar municipality, Nigeria
Islam et al. Prevalence and antimicrobial resistance patterns of Vibrio Cholerae from Bangladesh Agricultural University dairy farm
Sudeshika et al. Microbiological quality of paediatric oral liquid drug formulations during consumption

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180515